Silk Road Medical — Company Overview, News & Financial Data
Silk Road Medical develops devices to prevent strokes, specializing in the TCAR procedure for carotid artery disease.
Silk Road Medical
Company profile
About Silk Road Medical
Silk Road Medical (NASDAQ:SILK) specializes in developing and manufacturing medical devices focused on preventing strokes. The company is renowned for its innovative approach to treating carotid artery disease through its signature TransCarotid Artery Revascularization (TCAR) procedure, which is a less invasive alternative to traditional surgical techniques. Their commitment to improving patient outcomes drives their continuing research and development of groundbreaking products. Silk Road Medical aims to lead advancements in neurovascular health by expanding their product portfolio and enhancing the efficacy of stroke prevention methods.
Snapshot
2007Year founded
418Employees
Sunnyvale, United StatesHead office
Loading Map...
Global footprint
Operations
All Locations
Sunnyvale, US
Products and/or services of Silk Road Medical
- TransCarotid Artery Revascularization (TCAR) procedure uses the ENROUTE Transcarotid Neuroprotection and Stent System to treat carotid artery disease while reducing the risk of stroke.
- ENROUTE Transcarotid Stent System is designed specifically for use in TCAR procedures, providing a minimally invasive method to help prevent strokes in patients with carotid artery disease.
- ENROUTE Transcarotid Neuroprotection System (NPS) offers a unique method for preventing plaque from entering the brain during TCAR, aiming to reduce the risk of stroke.
- The ENHANCE Transcarotid Peripheral Access Kit for TCAR Procedures simplifies the process of gaining peripheral access, streamlining the procedure and improving outcomes.
- TCAR Clinical Support and Education Services provide comprehensive training and support for physicians and medical staff to ensure the successful implementation of the TCAR procedure.
- Research and Development in minimally invasive techniques for treating carotid artery disease, focusing on improving patient outcomes and expanding the applicability of TCAR.
Silk Road Medical executive team
- Mr. Charles S. McKhannCEO & Director
- Mr. Lucas W. BuchananCFO & COO
- Mr. Kevin M. KlemzExecutive VP, Chief Legal Officer & Secretary
- Ms. Erica J. RogersIndependent Consultant
- Mr. Andrew S. DavisChief Commercial Officer
- Mr. Richard M. RuedyExecutive Vice President of Clinical, Regulatory Affairs & Quality Assurance
- Ms. Mhairi L. JonesChief Accounting Officer & VP of Finance
- Ms. Tammy LeitsingerCompliance Officer & VP of Medical Affairs
- Mr. Jorge O'HaraVice President of Marketing, Business Development & Strategy
- Ms. Alison HighlanderVice President of Human Resources
GET YOUR GRAFA EDGE NOW
Sign up free to follow this company
We'll switch on a 30-day Edge trial as a welcome gift